The FDA pro­vid­ed tepid sup­port of Mod­er­na’s flu vac­cine ahead of an ad­vi­so­ry meet­ing but, more im­por­tant­ly, did­n't ap­pear to raise any ma­jor con­cerns that...

A group of health or­ga­ni­za­tions has ac­cused HHS of try­ing to use a “self-cre­at­ed cri­sis” to “rush re­in­state­ment” of the CDC’s frozen vac­cine ad­vi­so­ry pan­el...

The FDA gave the go-ahead for Col­orado to try im­port­ing cheap­er drugs from Cana­da, but it re­mains to be seen how or when this would...

Be Bio­phar­ma dis­closedin a fed­er­al clin­i­cal tri­als list­ing that it has ter­mi­nat­ed its study of a he­mo­phil­ia B ther­a­py made by edit­ing a pa­tient’s...

Plus, news about Mer­ck, Mul­ti­Va­lent Bio­ther­a­pies, Alvotech, en­Gene, Mirum, and Adap­tive Biotech­nolo­gies.

💸 Eli Lil­ly ac­quires an­oth­er pain biotech: The In­di­anapo­lis phar­ma gi­ant has made...

Edge­wise Ther­a­peu­tics has shared plans to ad­vance its drug can­di­date for a ge­net­ic heart dis­ease in­to a reg­is­tra­tional study on the back of up­dat­ed Phase 2...